About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials in Illinois | 816 Studies

Clinical Trials Lung CancerIllinois

Lung Cancer Clinical Trials in Illinois

Find 816 clinical trials for lung cancer near Illinois. Connect with research centers in your area.

All Lung Cancer trials nationwide All trials in Illinois

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 181-200 of 816 trials

TerminatedStudy of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal CancerA Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS mutated unresectable, locally…NCT05631574·Goodyear, Arizona and 22 others CompletedDocetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLCTo compare the overall survival of NSCLC patients receiving 2nd- or 3rd-line systemic therapy with docetaxel + plinabulin (DP Arm) to patients treated with docetaxel + placebo…NCT02504489·Chandler, Arizona and 56 others

Lung Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedAnti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung CancerThis is a Phase 2 study being conducted at multiple centers in the United States and Germany.NCT00094094·Irvine, California and 10 others

Active not recruitingCAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLCThe purpose of this clinical trial is to evaluate the effects of adding CAN-2409 + prodrug for stage III/IV NSCLC patients who are on standard of care first line immune checkpoint…NCT04495153·Phoenix, Arizona and 13 others

CompletedPaclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006229·Birmingham, Alabama and 68 others

CompletedA Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC)This open-label, multicenter study will assess the safety, tolerability, and pharmacokinetics of intravenous (IV) dosing of atezolizumab in combination with oral erlotinib or…NCT02013219·Orange, California and 16 others

Active not recruitingA Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)This study is researching an experimental drug called fianlimab (also called REGN3767), combined with a medication called cemiplimab (also called REGN2810), individually called a…NCT05785767·Tucson, Arizona and 105 others

CompletedPH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC PatientsThe main purpose of this study is to evaluate the overall safety and maximum dose of CI 1033 in combination with paclitaxel and carboplatin in patients with NSCLC.NCT00174356·Tampa, Florida and 6 others

CompletedLymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung CancerRATIONALE: Surgical removal of all lymph nodes in the chest may kill cancer cells that have spread from tumors in the lung.NCT00003831·Mobile, Alabama and 73 others

CompletedErlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and NeckThis phase I/II trial is studying the side effects of erlotinib and to see how well it works in treating patients with metastatic or unresectable non-small cell lung cancer…NCT00063895·Chicago, Illinois

CompletedDose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)* This was the first study where BAY1163877 was given to humans.NCT01976741·Chicago, Illinois and 28 others

WithdrawnTesting the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung CancerThis phase II trial tests the effect of atezolizumab given with usual chemotherapy during radiation therapy in treating patients with superior sulcus non-small cell lung cancer.NCT04989283·Jonesboro, Arkansas and 45 others

Active not recruitingA Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung CancerThe purpose of this research study is to compare the effects (good and bad) on subjects and their cancer using standard chemotherapy in combination with hypofractionated proton…NCT01770418·Jacksonville, Florida and 5 others

Active not recruitingAZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.To assess the efficacy and safety of AZD9291 versus Placebo, in patients with Epidermal Growth Factor Receptor Mutation Positive stage IB-IIIA non-small cell lung carcinoma…NCT02511106·Los Angeles, California and 237 others

CompletedStudy Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung CancerThe purpose of this study is to evaluate the safety and efficacy of the addition of veliparib plus carboplatin and paclitaxel versus the addition of placebo plus carboplatin and…NCT02106546·Jonesboro, Arkansas and 224 others

Active not recruitingProspective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC PatientsThe goal of the study is to collect data on patients treated outside of a clinical trial (in routine clinical practice) with standard of care osimertinib with or without…NCT06538038·Birmingham, Alabama and 145 others

CompletedCombination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With ChemotherapyThis study aims to assess the value of combined treatment with RAD001 and erlotinib in patients with advanced Non Small Cell Lung Cancer treated only with chemotherapy as systemic…NCT00456833·Atlanta, Georgia and 13 others

Active not recruitingStudy of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in META phase 1/2, first-in-human, open-label study of the safety, tolerability, PK, and efficacy of the novel MET/CSF1R/SRC inhibitor TPX-0022 in adult subjects with advanced or…NCT03993873·La Jolla, California and 23 others

TerminatedPh II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung CancerThe aim of this study is to combine AZD1775 with standard front-line chemotherapy in subjects with advanced NSCLC.NCT02087241·Englewood, Colorado and 7 others

CompletedA Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)This randomized Phase III, multicenter, open-label study designed to evaluate the safety and efficacy of atezolizumab (an engineered anti-programmed death-ligand 1 \[PD-L1\]…NCT02367781·Springdale, Arkansas and 131 others

PreviousPage 10 of 41Next

Other Conditions in Illinois

Breast Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma